Back
Pioneer Natural Resources Vs. Keros Therapeutics Industry Stock Comparison
Sell
46
PXD
Pioneer Natural Resources
Last Price:
269.97
Seasonality Move:
-1.59%
Sell
32
KROS
Keros Therapeutics
Last Price:
60.54
Seasonality Move:
-20.18%
Sell
46
Pioneer Natural Resources (PXD)
is a Sell
Is Pioneer Natural Resources a Buy, Sell or Hold?
- The current Pioneer Natural Resources [PXD] share price is $269.62. The Score for PXD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- PXD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $57.08. The Score for KROS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PXD Stock Price Chart
What is Pioneer Natural Resources's stock price today?
-
The Pioneer Natural Resources share price today is $269.62
The current trend is moderately bullish and PXD is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $57.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
PXD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.26 | Buy |
| Relative Strength Index (14 RSI): | 54.47 | Buy |
| Chaikin Money Flow: | -3053117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (267.13 - 273.89) | Sell |
| Bollinger Bands (100): | (223.02 - 261) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.69 | Sell |
| Relative Strength Index (14 RSI): | 43.98 | Sell |
| Chaikin Money Flow: | -159341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.38 - 63.26) | Sell |
| Bollinger Bands (100): | (45.16 - 66.32) | Buy |
PXD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 271.87 | Sell |
| 20-day SMA: | 271.36 | Sell |
| 50-day SMA: | 257.63 | Buy |
| 200-day SMA: | 238.03 | Buy |
| 8-day EMA: | 270.54 | Sell |
| 20-day EMA: | 269.08 | Buy |
| 50-day EMA: | 259.52 | Buy |
| 200-day EMA: | 240.01 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.65 | Buy |
| 20-day SMA: | 58.63 | Sell |
| 50-day SMA: | 63.26 | Sell |
| 200-day SMA: | 44.67 | Buy |
| 8-day EMA: | 57.24 | Sell |
| 20-day EMA: | 58.7 | Sell |
| 50-day EMA: | 59.52 | Sell |
| 200-day EMA: | 50.13 | Buy |
Pioneer Natural Resources Earnings Growth & PXD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.24 per share, an increase this year of $0.75 per share, and an increase next year of $1.34 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Pioneer Natural Resources Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||